Should I buy, hold, or sell MODD stock right now?

Modular Medical Inc. (MODD) currently earns a Roarable Rating of E (Strong Sell — SELL) with 33/100 RQD Confidence. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.

What is MODD's 12-month price target and RQD AI Jury consensus?

MODD's 12-month base price target is $1.6 (range $1.25 to $19.59), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Stock Ratings / Health Care / MODD

RVP (31) PAVM (28) CTSO (22) PMI (48) ⌘ Pro Terminal →

Modular Medical Inc. (MODD) — RQD Stock Rating Cockpit

$1.80 +4.65% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.81

Modular Medical Inc. (MODD) carries a Roarable Rating of E (Strong Sell) with 33/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $16.3M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on MODD Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is MODD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Modular Medical Inc. (NASDAQ: MODD) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $1.80 (+4.65% 1D, market cap $16.3M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 5/20. Across 1015 tracked Health Care issuers, MODD ranks #697 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does MODD compare to RVP and PAVM in the Health Care sector?

▼

Within the Health Care sector (Medical/Dental Instruments), MODD carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, RVP (Retractable Technologies Inc.) holds a E grade (31/100 RQD, P/E N/A, ROIC -23.3%, cap $16.9M) and PAVM (PAVmed Inc.) posts a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $15.6M). Among the 5-stock peer group, MODD leads on earnings multiple (N/A) while RVP leads on capital efficiency (-23.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for MODD?

▼

Per MODD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001074871), Modular Medical Inc. generated $77.2M in revenue (+44.7% YoY), -$28.2M in net income, and -$27.7M in free cash flow against $10.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.81 (+0.65%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 7/20 (D-) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (33/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-8.9% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-11.1% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MODD)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (33/100 Composite)

🔍 WHY MODD SCORES 33/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (30% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 2/9

▲ #2 Bullish Driver: Macro Regime Fit+8/20 pts (24% of score)

FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 39.2 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$2.14-8.9% Next Q

Q2 (-2Q)

Grade E$1.95-15.4% Next Q

Q3 (-1Q)

Grade E$1.65+9.1% Next Q

Current

Grade E$1.80-8.9% Hist 90D α

Trajectory: D (41) → E (33)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a MODD Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While MODD currently carries a cautious 33/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.43) and Max Pain ($1.89) forces dealer call-delta covering toward $19.59.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $MODD• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “MODD Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”

YES 33%NO 67%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

39.230 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCOREWEAK QUALITY (1–4)

2 / 99-Pt Accounting

52-WEEK LASER RANGE2% OF RANGE

L: $2$1.80H: $19

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: D-RQD 7 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: ERQD 8 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: DRQD 18 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on MODD

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (35)

-35.0% ROIC with 42.0% gross margin and 2.80% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BEARISH (50)

Altman-Z 4.20 and Piotroski 2/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (27)

8/40 institutional & smart-money positioning score with 8/20 macro alignment.

Bull Case: Why Buyers Like MODD

✓Established market leader in Health Care with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Sensitive to high interest rates and tighter Federal Reserve market liquidity.
!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MODD)

✓Walkthrough of MODD's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MODD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -55.77%🛡️ HOLDING TREND SUPPORT

2026-11-03O $1.72H $1.80L $1.72C $1.80VOL 20.6K

RES: $2.42SUP: $1.50SMA50: $2.43SMA200: $5.12

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MODD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MODD Butterfly Map → + Track MODD →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

8.0%/yr Implied 5Y Growth

vs. +44.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on MODD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MODD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MODD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MODD)

Health Care Rank #697 of 1015 ⚔️ RVP vs MODD Full Matrix →

1. Head-to-Head Health Care Peer Comparison (MODD vs. RVP, PAVM, CTSO, PMI)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Modular Medical Inc. (MODD) ranks #697 by composite RQD confidence (33/100, grade E) and #845 by equity capitalization ($16.3M). Within this direct 5-issuer industry benchmark cohort, MODD leads on earnings valuation at N/A trailing P/E, while RVP leads on capital efficiency and profitability with -23.3% ROIC and 0.1% gross margin. PMI currently holds the highest overall quantitative score in the immediate peer group at 48/100 (D) compared with MODD at 33/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MODD ACTIVE Modular Medical Inc.	E	33/100	—	—	-35.0%	+4.65%	$16.3M	Benchmark Subject
RVP Retractable Technologies Inc.	E	31/100	—	0.1%	-23.3%	+0.18%	$16.9M	/rvp-vs-modd →
PAVM PAVmed Inc.	E	28/100	—	-30.0%	-35.0%	-2.05%	$15.6M	/pavm-vs-modd →
CTSO Cytosorbents Corporation	E	22/100	—	71.5%	-35.0%	-9.25%	$14.3M	/ctso-vs-modd →
PMI Picard Medical Inc.	D	48/100	—	—	—	+2.75%	$20.5M	/pmi-vs-modd →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0001074871 ↗

In its most recent audited fiscal period (FY2025, filed 2026-03-31), Modular Medical Inc. (MODD) reported GAAP revenue of $77.2M (+44.7% vs. FY2024 revenue of $53.3M , and +57.2% cumulative change since FY2023) , GAAP net income of -$28.2M, operating cash flow of -$23.8M, and free cash flow of -$27.7M (-52.0% YoY). On the balance sheet, MODD closed FY2025 with $10.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2026-03-31	$77.2M	-$28.2M	-$23.8M	-$27.7M	$10.3M	—
FY2024 (FY)	2025-03-31	$53.3M	-$18.8M	-$15.7M	-$18.2M	$12.1M	—
FY2023 (FY)	2024-03-31	$49.1M	-$17.5M	-$14.0M	-$14.0M	—	—

3. MODD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MODD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does MODD compare to RVP and PAVM in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for MODD?

Where is MODD trading relative to its 50-day, 200-day, and 52-week technical levels?

MODD last traded at $1.80 (+4.65% on volume of 60,976 shares), positioning the stock -25.93% below its 50-day simple moving average ($2.43) and -64.84% below its 200-day simple moving average ($5.12). Across its 52-week range of $1.52 to $18.66, MODD sits at the 1.6% percentile with a 14-day RSI of 39.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.57 to $2.03).

Direct Sub-Reports: MODD RQD Cockpit MODD 12M Forecast MODD Earnings & Move MODD Dividends & DRIP MODD Insiders & 13F MODD Whale Options MODD Profit Sankey MODD News & Why

ROARABLE RATING BRIEF • RQD 33/100 (E) ✓ SEC XBRL & RQD VERIFIED

MODD — Modular Medical Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2026-03-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Modular Medical Inc. (MODD) earns a live Roarable RQD composite score of 33/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $1.80 (+4.65% 1D, market capitalization $16.3M).

Fundamental Cash Engine (7/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of —, operating margin of —, and free cash flow yield of —.
Whale 13F & Options Flow (3/20) + Insider Conviction (5/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (8/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 2/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Modular Medical Inc. (MODD) is listed on NASDAQ and operates in the Health Care sector, within the Medical/Dental Instruments industry. The profile does not describe its products, customers, or revenue model. Reported revenue is — for each period presented.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2026-03-31), Modular Medical Inc. (MODD) reported $77.2M in annual revenue (up from $53.3M in FY2024, +44.7% YoY) and -$28.2M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($49.1M revenue, -$17.5M net income) through FY2025, MODD scaled operating cash flow to -$23.8M and free cash flow to -$27.7M, backed by $10.3M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (E • RQD 33/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 3/20. With Fundamental Cash Engine at 7/20 and Institutional Whale Flow at 3/20, sustained execution supports upside toward the upper end of the $1.52 – $18.66 52-week range.
🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

There are no upstream or downstream links, no sector correlation links, and no proprietary signals recorded. The stated supply chain is NONE. Therefore, specific upstream dependencies, downstream customers, and 2nd-order bottlenecks are — A prospective investor should note that the regulatory items in the news feed (ISO 13485:2016 certification and the separate EU sales review) are the most concrete 2nd-order dependencies implied by the sources, and that the timing of any EU sales authorization is not specified.

Key Question #1: Can MODD sustain or expand its — operating margin and -35.0% ROIC against Medical/Dental Instruments peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $77.2M and free cash flow of -$27.7M, how will capital allocation balance growth reinvestment against $0 in total debt?
Key Question #3: How sensitive is MODD's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

MODD Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Modular Medical Inc. (MODD) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to MODD Debate Forum (3) ↓

🟡 MARKET WIRE StockInvest.us • 22h ago

Modular Medical Stock Price Forecast. Should You Buy MODD?

StockInvest.us report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 1d ago

A tubeless insulin pump is designed for three-day wear. Modular Medical's CEO is set to speak Oct. 14.

Stock Titan report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 1d ago

Modular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14th

Yahoo Finance report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Modular Medical Announces Positive Notified Body Decision on ISO 13485:2016 Certification

Yahoo Finance report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Benzinga • 1d ago

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 1d ago

A pump maker gets a positive decision on quality certification. EU sales still require separate review.

Stock Titan report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST https://www.siam.in/ • 1d ago

Modular Medical (MODD) Jumps 18.7% to $2.73, Pressing Toward Resistance - Volume Breakout Ideas

https://www.siam.in/ report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH https://www.dars.gov.et/ • 1d ago

MODD Q3 2025 Earnings: Wider-Than-Expected Loss Per Share as Development-Stage Device Maker Posts No Reported Revenue - ROA Comparison

https://www.dars.gov.et/ report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

MODD Bull vs. Bear Conversation Board — What's Your Call at $1.80?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON MODD 🐻 33% BEARISH CONVICTION

MA MacroHawk_NYC RQD DEBATE OPENER • Cross-Asset Macro Desk 🐂 BULLISH 🎯 Target: $2.25 (+30.8%)

📌 Pinned Debate

MODD (E • RQD 33/100) operating leverage in Medical/Dental Instruments is mispriced at $1.72

Don't sleep on MODD's setup in Health Care. MODD (E • RQD 33/100) operating leverage in Medical/Dental Instruments is mispriced at $1.72. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (33/100) backs up the fundamental quality.

RetailWhale_TX 🐂 BULL

@CreditSpread_Watch Shorting a 3/20 institutional whale-flow stock at $1.72 is dangerous when funds are rotating into Health Care.

CR CreditSpread_Watch RQD DEBATE OPENER • Balance Sheet Analyst 🐻 BEARISH 🎯 Target: $1.44 (-16.3%)

Spot @ $1.72

With -$27.7M of FY 2025 free cash flow against $2.9M of cash and a -35% ROIC, the company has no revenue and a weak Piotroski score of

I respect the product at Modular Medical Inc., but the stock at $1.72 is a different story. With -$27.7M of FY 2025 free cash flow against $2.9M of cash and a -35% ROIC, the company has no revenue and a weak Piotroski score of 2/9.. FCF yield is 0.0% and RQD sits at 33/100 (E) — why pay up here when you can wait for next quarter's numbers?